NCT04831736View on ClinicalTrials.gov

Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

March 29, 2022

Study Completion Date

March 29, 2022

Conditions
Postoperative Pain
Interventions
DRUG

Ketamine

Ketamine at a dose of 0.6 mg/kg will be administered intravenously (IV) while the participant is recovering in the PACU. The study drug will be administered over at least 30 minutes at one time point and will be administered after subject has been deemed to be stable (hemodynamically stable, awake) by the study team on POD 0.

DRUG

Placebo

Matching equal dose of saline placebo will be administered intravenously while the participant is recovering in the PACU.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER